Jewell Christopher M 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Jewell Christopher M
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-01-02+47,400→ 47,400 totalExercise: $16.93Exp: 2035-01-01→ Common Stock (47,400 underlying) - Award
Common Stock
2025-01-02+16,100→ 56,040 total
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.
- [F2]This option vests as to 25% on January 2, 2026. The remainder of the underlying shares will vest in three equal annual installments thereafter so that the underlying shares will be fully vested on January 2, 2029.